首页> 外文期刊>The journal of clinical endocrinology and metabolism >Thyrotropin and Thyroid Antibodies as Predictors of Hypothyroidism: A 13-Year, Longitudinal Study of a Community-Based Cohort Using Current Immunoassay Techniques
【24h】

Thyrotropin and Thyroid Antibodies as Predictors of Hypothyroidism: A 13-Year, Longitudinal Study of a Community-Based Cohort Using Current Immunoassay Techniques

机译:甲状腺激素和甲状腺抗体作为甲状腺功能亢进的预测因子:13年,使用电流免疫测定技术的基于社区的队列的纵向研究

获取原文
       

摘要

Context: Longitudinal studies of risk factors for hypothyroidism are required to inform debate regarding the TSH reference range. There are limited longitudinal data on the predictive value of thyroid antibodies measured by automated immunoassay (as opposed to semiquantitative methods).Methods: We measured TSH, free T_(4), thyroid peroxidase antibodies (TPOAbs), and thyroglobulin antibodies (TgAbs) using the Immulite platform on sera from 1184 participants in the 1981 and 1994 Busselton Health Surveys. Outcome measures at follow-up were hypothyroidism, defined as TSH greater than 4.0 mU/liter or on thyroxine treatment; and overt hypothyroidism, defined as TSH above 10.0 mU/liter or on thyroxine treatment. Receiver-operator characteristic analysis was used to determine optimal cutoffs for baseline TSH, TPOAbs, and TgAbs as predictors of hypothyroidism.Results: At 13 yr follow-up, 110 subjects (84 women) had hypothyroidism, of whom 42 (38 women) had overt hypothyroidism. Optimal cutoffs for predicting hypothyroidism were baseline TSH above 2.5 mU/liter, TPOAbs above 29 kIU/liter, and TgAbs above 22 kIU/liter, compared with reference range upper limits of 4.0 mU/liter, 35 kIU/liter, and 55 kIU/liter, respectively. In women with positive thyroid antibodies (TPOAbs or TgAbs), the prevalence of hypothyroidism at follow-up (with 95% confidence intervals) was 12.0% (3.0–21.0%) when baseline TSH was 2.5 mU/liter or less, 55.2% (37.1–73.3%) for TSH between 2.5 and 4.0 mU/liter, and 85.7% (74.1–97.3%) for TSH above 4.0 mU/liter.Conclusions: The use of TSH cutoffs of 2.5 and 4.0 mU/liter, combined with thyroid antibodies, provides a clinically useful estimate of the long-term risk of hypothyroidism.
机译:背景信息:需要对甲状腺功能亢进的危险因素进行纵向研究,以便为TSH参考范围提供辩论。通过自动免疫测定法测量的甲状腺抗体的预测值有限(与半定量方法)。方法:我们测量TSH,FREE T_(4),甲状腺过氧化物酶抗体(TPOABs)和甲状腺球蛋白抗体(TGABs) 1981年和1994年Busselton Health Murerveys的1184名参与者的血清Immulite平台。随访的结果措施是甲状腺功能减退症,定义为大于4.0亩/升或甲状腺处理的TSH;和明显的甲状腺功能减退症,定义为10.0亩/升或甲状腺处理的TSH。接收器 - 操作员特征分析用于确定基线TSH,TPOAB和TGAB的最佳截止,作为甲状腺功能亢进的预测因子。结果:在13年随访中,110名受试者(84名女性)有甲状腺功能减退症,其中42名(38名女性)公开甲状腺功能减退症。用于预测甲状腺功能减退症的最佳截止值是基线TSH以上2.5亩/升,TPOABs高于29 kiu /升,22 kiu /升的TGAB,与参考范围为4.0 mu /升,35 kiu /升和55 kiu /升分别。在含有阳性甲状腺抗体(TPOABs或TGAB)的女性中,当基线TSH为2.5亩/升或更低时,55.2%( 37.1-73.3%)对于2.5和4.0亩/升之间的TSH,85.7%(74.1-97.3%)以上4.0 mu /升。结论:使用TSH截止值2.5和4.0亩/升,与甲状腺相结合抗体,提供对甲状腺功能亢进的长期风险的临床有用的估计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号